Wescott Financial Advisory Group, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1864880
Philadelphia, PA
Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$468,721
-$48,899 QoQ
Shares Held
3,710
-0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,401
of 2,266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wescott Financial Advisory Group, LLC holds $34,430,041 across 6 Drug Manufacturers - General names. GILD ranks #4 (1.4% of the industry book) .
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $468,721 | 3,710 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $517,620 | 3,714 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $450,210 | 3,668 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $393,606 | 3,546 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $393,699 | 3,551 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $400,018 | 3,570 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $328,190 | 3,553 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $282,624 | 3,371 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $230,872 | 3,365 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||